Where can researchers source third-party tested MOTS-c?

Midwest Peptide supplies research-grade MOTS-c with a Certificate of Analysis included for every batch, validated by HPLC purity and mass spectrometry identity testing.

Age Verification

You must be 21 years or older to access this website. All products are for research use only.

Are you 21 years of age or older?

By entering, you confirm that you are at least 21 years old and agree to our terms of service.

Free shipping on every orderFree shipping on every order

5% off with Zelle or Apple CashSave an extra 5% when you pay with Zelle or Apple Cash

Bulk pricing discounts up to 18%Bulk pricing discounts up to 18% off

MOTS-c Insulin Sensitivity Research | Midwest Peptide

MOTS-c Obesity Research: Diet-Induced Adiposity Animal Model LiteraturePrev|Where to Buy DSIP for Research: Delta Sleep-Inducing Peptide Sourcing GuideNext

MOTS-c Insulin Sensitivity Research: Skeletal Muscle Glucose Uptake Studies

MOTS-c · Published April 14, 2026 · Updated May 18, 2026 · 7 min read

Quick Answer

MOTS-c insulin sensitivity research examines skeletal muscle glucose uptake, GLUT4 translocation, and AMPK pathway activation in rodent models. Studies measure glucose disposal rates, insulin signaling biomarkers, and muscle metabolism dynamics across standardized insulin sensitivity research protocols. For research use only, not for human consumption.

MOTS-c Insulin Sensitivity Research: Skeletal Muscle Glucose Uptake Studies

Research Use Only. All products are strictly for research use only (RUO). Not for human consumption. Products on this site are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. By purchasing, you agree that you are a qualified researcher and that products will be used solely for in-vitro research purposes.

Skeletal Muscle Glucose Uptake Biology
Published MOTS-c Research in Muscle Glucose Metabolism
Insulin Sensitivity Measurement Methods
AMPK Pathway Downstream Effects
Relationship to Exercise Research
Adipose Tissue Insulin Sensitivity
Research Peptide Referenced
Related Research Reading
Related Research Articles
Explore Related Products
Frequently Asked Questions
Glossary

MOTS-c insulin sensitivity research extends the MOTS-c research cluster into the skeletal muscle glucose metabolism that represents one of the core physiological functions of the mitochondrial derived peptide. The AMPK pathway activation documented in the metabolic homeostasis research has direct consequences for insulin sensitivity in skeletal muscle and other metabolic tissues, and this article reviews the specific research on insulin sensitivity endpoints.

Frequently Asked Questions

What is MOTS-c in research contexts?

MOTS-c is a 16-amino-acid mitochondrial-derived peptide encoded within the 12S rRNA region of mitochondrial DNA. It is studied in preclinical research as an exercise mimetic, an AMPK activator, and a regulator of metabolic homeostasis and aging biology.

How does MOTS-c affect insulin sensitivity?

MOTS-c activates skeletal muscle AMPK, which translocates GLUT4 to the plasma membrane independently of insulin signaling, enhancing glucose uptake. The peptide also improves insulin signaling efficiency, contributing to improved overall glucose homeostasis in research models.

What insulin sensitivity endpoints are measured with MOTS-c?

Endpoints include glucose tolerance tests, hyperinsulinemic-euglycemic clamps, GLUT4 translocation assays in muscle, AMPK and ACC phosphorylation status, and integrated assessment of muscle glucose disposal capacity.

Is MOTS-c approved for human use?

No. MOTS-c is not approved by the FDA for any human therapeutic use. It is supplied strictly for in-vitro and preclinical research purposes by qualified investigators.

Glossary

Key terms used in this article.

Mitochondrial-Derived Peptide (MDP): A class of small bioactive peptides encoded within the mitochondrial genome and translated within or near mitochondria.
AMPK: AMP-activated protein kinase, a cellular energy sensor activated under low ATP conditions to restore metabolic homeostasis.
Exercise Mimetic: A compound that produces molecular and physiological adaptations associated with physical exercise without requiring activity.
Mitochondrial Biogenesis: The cellular process of generating new mitochondria, regulated by PGC-1 alpha and other transcriptional coactivators.
GLUT4: Glucose transporter type 4, the insulin-responsive glucose transporter in skeletal muscle and adipose tissue.
Hyperinsulinemic-Euglycemic Clamp: The gold standard technique for measuring insulin sensitivity in vivo by infusing insulin and glucose to maintain euglycemia.

More from the Blog

Continue exploring research insights and updates.

Subcutaneous vs Intranasal: Choosing an Administration Route for DSIP, Selank, and Kisspeptin in Research

Subcutaneous vs intranasal administration for CNS-targeted research peptides: how to choose between routes for DSIP, Selank, and Kisspeptin based on molecular size, brain access, pharmacokinetics, and the published literature.

May 5, 2026

Can I Still Buy Compounded Tirzepatide? (2026 Research Context)

FDA restricted compounded tirzepatide for human use when the shortage ended. The Research Use Only research peptide channel for tirzepatide (GLP-2 TZ) operates under entirely separate regulations.

May 5, 2026

For Research Use Only. MOTS-c is intended strictly for in vitro and preclinical animal research. It is not approved for human use, is not a drug, and should never be administered to humans.

Skeletal Muscle Glucose Uptake Biology

Skeletal muscle is the primary site of insulin stimulated glucose disposal in the postprandial state. Insulin signaling through muscle insulin receptors activates the phosphatidylinositol 3-kinase Akt pathway, which translocates GLUT4 glucose transporters from intracellular vesicles to the plasma membrane. The membrane GLUT4 then facilitates glucose uptake down its concentration gradient into the muscle cell. The integrated biology is documented in primary research archived at the Nature subject hub on insulin signaling.

In insulin resistance, the insulin stimulated GLUT4 translocation is impaired at multiple steps including reduced insulin receptor signaling, reduced PI3K activation, reduced Akt phosphorylation, and reduced GLUT4 trafficking. The result is reduced glucose uptake into muscle tissue and elevated circulating glucose in the postprandial state. Interventions that restore insulin stimulated glucose uptake in muscle are of substantial research interest in obesity and diabetes research.

An alternative pathway for glucose uptake into muscle is the insulin independent AMPK activated pathway. AMPK activation in muscle stimulates GLUT4 translocation through a distinct signaling chain that does not require insulin receptor signaling. Exercise activates this pathway through mechanical and metabolic signals, which is why exercise is effective in improving glucose regulation even in insulin resistant conditions. MOTS-c research engages this same pathway through its AMPK activating properties, which provides the mechanistic basis for the insulin sensitivity findings.

Published MOTS-c Research in Muscle Glucose Metabolism

Published research on MOTS-c effects on skeletal muscle glucose uptake has been conducted in both in vitro and in vivo rodent models. The in vitro research uses isolated muscle preparations or cultured muscle cell lines with controlled glucose uptake measurements. The in vivo research uses rodent models of obesity and insulin resistance with systemic glucose regulation endpoints and with direct muscle glucose uptake measurements using isotope tracer methods.

The in vitro findings document increased glucose uptake in MOTS-c treated muscle preparations compared to vehicle treated controls. The magnitude of effect is reproducible across laboratories and is consistent with AMPK mediated GLUT4 translocation. The mechanism has been confirmed through pharmacological AMPK inhibition, which abolishes the MOTS-c effect on glucose uptake.

The in vivo findings in rodent insulin resistance models document improved glucose tolerance, reduced fasting glucose, and reduced fasting insulin under MOTS-c administration. The effects translate the in vitro cellular findings to whole animal metabolic outcomes. The Cell Press journal Cell Metabolism and the ScienceDirect AMPK topic page both archive primary research on the integrated biology.

Insulin Sensitivity Measurement Methods

Research on insulin sensitivity uses several measurement approaches. The hyperinsulinemic euglycemic clamp is the reference method and provides the most direct quantification of insulin sensitivity in whole animal studies. The clamp protocol infuses insulin at a defined rate while measuring the glucose infusion rate needed to maintain constant glycemia. Higher glucose infusion rates indicate better insulin sensitivity.

Less invasive methods include the oral or intraperitoneal glucose tolerance test, which measures blood glucose response to a glucose challenge. The insulin tolerance test measures blood glucose response to exogenous insulin and reflects the combined action of insulin on glucose production and glucose disposal. Homeostatic model assessment of insulin resistance uses fasting glucose and fasting insulin values in a calculation that provides a convenient index.

Published MOTS-c research has used several of these methods with consistent findings of improved insulin sensitivity across the various measurement approaches. The consistency across methods strengthens the interpretation that MOTS-c produces a real effect on insulin sensitivity rather than an artifact of any particular measurement system.

AMPK Pathway Downstream Effects

The AMPK pathway activation by MOTS-c has downstream effects beyond just GLUT4 translocation. AMPK activity modulates fatty acid oxidation through phosphorylation of acetyl coenzyme A carboxylase, which reduces malonyl coenzyme A production and allows fatty acids to enter the mitochondria for oxidation. AMPK activity also modulates mitochondrial biogenesis through PGC-1 alpha activation, which increases mitochondrial content and oxidative capacity over time.

These downstream effects contribute to the sustained improvements in muscle metabolic function documented under chronic MOTS-c administration. The acute effects on glucose uptake through GLUT4 translocation operate quickly, while the chronic effects on mitochondrial content and oxidative capacity develop over days to weeks of administration. The combined acute and chronic effects produce the integrated metabolic phenotype documented in the MOTS-c literature.

The Wiley Online Library metabolism collection and the Frontiers in Physiology open access journal archive primary research on these integrated AMPK downstream pathways.

Relationship to Exercise Research

The MOTS-c exercise research article in this cluster covers the relationship between MOTS-c and exercise biology in detail. The insulin sensitivity findings connect to this exercise context because exercise produces many of the same metabolic effects through similar AMPK pathway activation. The research interpretation is that MOTS-c acts as a pharmacological mimic of some aspects of exercise biology, particularly the AMPK activation and the downstream metabolic effects.

This exercise mimetic interpretation has implications for research design because studies that want to isolate the MOTS-c specific effects need to account for the baseline activity level of the research animals. Animals with higher baseline activity may show smaller relative effects of MOTS-c because their AMPK pathway is already more activated by the behavioral activity. Conversely, sedentary animal models may show larger relative effects of MOTS-c because the baseline AMPK activation is lower.

Age Verification

MOTS-c Insulin Sensitivity Research: Skeletal Muscle Glucose Uptake Studies

Frequently Asked Questions

What is MOTS-c in research contexts?

How does MOTS-c affect insulin sensitivity?

What insulin sensitivity endpoints are measured with MOTS-c?

Is MOTS-c approved for human use?

Glossary

More from the Blog

Subcutaneous vs Intranasal: Choosing an Administration Route for DSIP, Selank, and Kisspeptin in Research

Can I Still Buy Compounded Tirzepatide? (2026 Research Context)

Skeletal Muscle Glucose Uptake Biology

Published MOTS-c Research in Muscle Glucose Metabolism

Insulin Sensitivity Measurement Methods

AMPK Pathway Downstream Effects

Relationship to Exercise Research

Adipose Tissue Insulin Sensitivity

Research Peptide Referenced

Ready to Start Your Research?

Where can researchers source third-party tested MOTS-c?

What's the Cheapest Way to Get Tirzepatide (GLP-2 TZ) for Research?

Age Verification

MOTS-c Insulin Sensitivity Research: Skeletal Muscle Glucose Uptake Studies

Frequently Asked Questions

What is MOTS-c in research contexts?

How does MOTS-c affect insulin sensitivity?

What insulin sensitivity endpoints are measured with MOTS-c?

Is MOTS-c approved for human use?

Glossary

More from the Blog

Subcutaneous vs Intranasal: Choosing an Administration Route for DSIP, Selank, and Kisspeptin in Research

Can I Still Buy Compounded Tirzepatide? (2026 Research Context)

Skeletal Muscle Glucose Uptake Biology

Published MOTS-c Research in Muscle Glucose Metabolism

Insulin Sensitivity Measurement Methods

AMPK Pathway Downstream Effects

Relationship to Exercise Research

Adipose Tissue Insulin Sensitivity

Research Peptide Referenced

Related Research Reading

Related Research Articles

Explore Related Products

Ready to Start Your Research?

Where can researchers source third-party tested MOTS-c?

What's the Cheapest Way to Get Tirzepatide (GLP-2 TZ) for Research?